MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 53 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $172,756 | -50.6% | 36,066 | -29.4% | 0.00% | – |
| Q2 2023 | $349,898 | +17.5% | 51,080 | +33.6% | 0.00% | – |
| Q1 2023 | $297,811 | -63.7% | 38,230 | -64.5% | 0.00% | – |
| Q4 2022 | $819,574 | -17.7% | 107,697 | -11.8% | 0.00% | – |
| Q3 2022 | $996,000 | -26.2% | 122,123 | -12.6% | 0.00% | – |
| Q2 2022 | $1,350,000 | -28.5% | 139,649 | +3.7% | 0.00% | – |
| Q1 2022 | $1,888,000 | -32.0% | 134,679 | -0.9% | 0.00% | – |
| Q4 2021 | $2,775,000 | +32.6% | 135,939 | +44.8% | 0.00% | – |
| Q3 2021 | $2,092,000 | – | 93,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |